AHF and Society for AIDS in Africa Convene High-Level Summit to Advance Regional Health Leadership and Sustainable Health Financing in Africa at ICASA 2025 The AIDS Healthcare Foundation (AHF) Global Public Health Institute, in partnership with The Society for AIDS…
Arrowhead Pharmaceuticals Reports Fiscal Year 2025 Financial Results and Highlights Major Regulatory and Clinical Milestones Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced its financial results for the fiscal year ending September 30, 2025, alongside a comprehensive review of recent scientific,…
Real-World Study Shows Durable Cardiovascular Protection with Repatha Target RWE, a leading organization in modern real-world evidence (RWE) generation and a trusted partner for regulatory-grade research, has announced significant new findings from the REPATHA-CE study—now recognized as the largest real-world…
ReAlta Life Sciences Strengthens Leadership Team with Appointment of Dr. Howard Berman as Executive Chairman ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company pioneering next-generation medicines designed to safely modulate neutrophils and the complement system, today…
Pathway to Cures Invests in SeraGene Therapeutics The fifth paragraph of the original release dated November 19, 2025, should read: Pathway to Cures joins Hextwo Capital as early investors in SeraGene Therapeutics.The fully updated and expanded release appears below. PATHWAY…
Kelonia Therapeutics Announces Late-Breaking Oral Presentation Showcasing First-in-Human Data for KLN-1010, an In Vivo BCMA CAR-T Gene Therapy, at ASH 2025 Kelonia Therapeutics, Inc., a clinical-stage biotechnology company advancing a next-generation approach to genetic medicines through in vivo gene delivery,…
AstraZeneca Announces $2 Billion Expansion to Strengthen Maryland Manufacturing, Advance Innovation, and Support 2,600 Jobs AstraZeneca today unveiled a major strategic investment plan totaling $2 billion to expand its long-standing manufacturing presence in Maryland, further solidifying the state’s role as…
AGC Biologics and AAVantgarde Forge New Manufacturing Partnership to Advance Dual-Vector Gene Therapies for Inherited Retinal Diseases Following AAVantgarde Bio’s recent completion of a successful Series B financing round, the company has taken another major step forward in advancing its…
Hercules Pharmaceuticals Announces Membership in the Healthcare Distribution Alliance and Board Appointment of Timothy Ward Hercules Pharmaceuticals (Hercules), a national leader in pharmaceutical distribution and a rapidly growing provider-aligned group purchasing organization (GPO), announced today that it has officially joined…
BeOne Medicines Announces Positive Phase 3 HERIZON-GEA-01 Results Supporting ZIIHERA®-Based Regimens as Transformative First-Line Options for HER2-Positive Gastroesophageal Adenocarcinoma BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company committed to developing innovative therapies for hard-to-treat cancers,…
Arrowhead Pharmaceuticals Announces FDA Approval of REDEMPLO® (plozasiran), Marking a Major Advancement in Treatment for Familial Chylomicronemia Syndrome Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced a landmark achievement today with the U.S. Food and Drug Administration’s (FDA) approval of REDEMPLO® (plozasiran).…
ChristianaCare Establishes Organoid Core to Power Precision Cancer Treatment ChristianaCare’s Cawley Center for Translational Cancer Research has launched a groundbreaking organoid core—marking the first time such an advanced, patient-specific modeling platform has been established within a community cancer center program…